Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT02525380 · UNKNOWN
Trial details
- NCT number
- NCT02525380
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.